Squarepoint Ops LLC Buys New Holdings in Global Medical REIT Inc (GMRE)

Squarepoint Ops LLC bought a new position in shares of Global Medical REIT Inc (NYSE:GMRE) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,315 shares of the company’s stock, valued at approximately $118,000. Squarepoint Ops LLC owned approximately 0.06% of Global Medical REIT as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Schnieders Capital Management LLC purchased a new stake in shares of Global Medical REIT in the 4th quarter valued at approximately $116,000. Martingale Asset Management L P purchased a new stake in shares of Global Medical REIT in the 3rd quarter valued at approximately $285,000. Janney Montgomery Scott LLC lifted its position in shares of Global Medical REIT by 1.1% in the 4th quarter. Janney Montgomery Scott LLC now owns 111,188 shares of the company’s stock valued at $988,000 after acquiring an additional 1,181 shares in the last quarter. BlackRock Inc. lifted its position in shares of Global Medical REIT by 0.9% in the 3rd quarter. BlackRock Inc. now owns 1,020,193 shares of the company’s stock valued at $9,609,000 after acquiring an additional 9,460 shares in the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Global Medical REIT by 0.9% in the 3rd quarter. Vanguard Group Inc. now owns 899,741 shares of the company’s stock valued at $8,475,000 after acquiring an additional 7,614 shares in the last quarter. Hedge funds and other institutional investors own 41.76% of the company’s stock.

Several brokerages recently commented on GMRE. B. Riley set a $11.00 price target on shares of Global Medical REIT and gave the company a “buy” rating in a research report on Friday, March 8th. Boenning Scattergood reiterated a “buy” rating on shares of Global Medical REIT in a research report on Thursday, March 7th. Zacks Investment Research upgraded shares of Global Medical REIT from a “hold” rating to a “buy” rating and set a $11.00 target price for the company in a research report on Wednesday, February 13th. Finally, Stifel Nicolaus began coverage on shares of Global Medical REIT in a research report on Monday, April 15th. They issued a “buy” rating and a $11.00 target price for the company. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Global Medical REIT currently has an average rating of “Buy” and an average target price of $10.67.

GMRE stock opened at $10.09 on Friday. Global Medical REIT Inc has a 12-month low of $7.55 and a 12-month high of $11.02. The company has a debt-to-equity ratio of 1.25, a current ratio of 0.11 and a quick ratio of 0.11. The company has a market capitalization of $265.60 million, a price-to-earnings ratio of 12.94, a P/E/G ratio of 1.35 and a beta of 0.61.

Global Medical REIT (NYSE:GMRE) last released its earnings results on Thursday, March 7th. The company reported $0.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.21 by $0.10. Global Medical REIT had a net margin of 22.62% and a return on equity of 6.29%. The company had revenue of $14.38 million during the quarter, compared to the consensus estimate of $14.46 million. On average, research analysts expect that Global Medical REIT Inc will post 0.83 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 10th. Shareholders of record on Tuesday, March 26th were given a $0.20 dividend. The ex-dividend date of this dividend was Monday, March 25th. This represents a $0.80 dividend on an annualized basis and a yield of 7.93%. Global Medical REIT’s payout ratio is 102.56%.

In other Global Medical REIT news, Director Roscoe M. Moore, Jr. sold 5,945 shares of the stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $9.75, for a total value of $57,963.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 13.00% of the stock is owned by corporate insiders.

WARNING: This piece was originally reported by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/squarepoint-ops-llc-buys-new-holdings-in-global-medical-reit-inc-gmre.html.

Global Medical REIT Company Profile

Global Medical REIT, Inc engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Featured Story: Does the discount rate affect the economy?

Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc (NYSE:GMRE).

Institutional Ownership by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.